Physician profile
Janet L Honchell
NPI 1053678359
$1,547.22
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $149 · 2021: $600 · 2022: $358 · 2023: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $445.29 | 2019-2023 | |
| Aspira Women'S Health INC | $364.48 | 2021-2023 | Ova1 |
| Amgen INC. | $189.43 | 2021-2022 | |
| Therapeuticsmd, INC. | $100.15 | 2019-2022 | |
| Hologic Sales and Service, LLC | $93.96 | 2019-2023 | Aptima, Affirm Prone Biopsy System |
| Allergan, INC. | $71.29 | 2019-2020 | |
| Exact Sciences Corporation | $50.84 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $42.71 | 2021-2023 | |
| Agile Therapeutics, INC. | $33.39 | 2021-2023 | Twirla |
| Avion Pharmaceuticals | $25.37 | 2022-2023 | Balcoltra |
| Ascend Therapeutics US, LLC | $17.60 | 2020 | |
| Astellas Pharma US INC | $17.37 | 2023 | Myrbetriq |
| Virtus Pharmaceuticals LLC | $16.29 | 2021 | |
| Mayne Pharma Commercial LLC | $14.27 | 2022 | |
| Merck Sharp & Dohme LLC | $13.75 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $13.62 | 2019 | |
| Alfasigma USA, INC. | $12.89 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.85 | 2020 | |
| Zyla Life Sciences, INC. | $11.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Honchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.